Case Study: How a Life Science Startup Chose Their First Market (And Why It Wasn’t the Obvious One)
SingleStar had three viable markets for its bioprocessing equipment: large biopharma companies with large budgets, emerging biotechs growing rapidly, and non-GMP CDMOs facing urgent supply constraints. With only 12-18 months of runway and no market reputation, which should they choose?
This life sciences ICP example shows how SingleStar used the customer discovery framework to evaluate all three options systematically—and why they chose non-GMP CDMOs as their beachhead despite lower revenue per customer.
See their complete decision matrix, documented ideal customer profile with specific needs like “zero contamination because events cost $50K-$200K,” and how this single choice shaped their pricing, messaging, and product roadmap.
Learn how constraints (not just opportunities) should drive your ICP decision, and why the beachhead market strategy works for life sciences startups with limited runway.